Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study

Background: An increasing number and proportion of cancer patients with apparently localised disease are treated with chemotherapy and radiation therapy in contemporary oncology practice. In a pilot study of radiation-induced sarcoma (RIS) patients, we demonstrated that chemotherapy was associated w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2017-07, Vol.117 (3), p.326-331
Hauptverfasser: Zhang, A Y, Judson, I, Benson, C, Wunder, J S, Ray-Coquard, I, Grimer, R J, Quek, R, Wong, E, Miah, A B, Ferguson, P C, Dufresne, A, Teh, J Y H, Stockler, M, Tattersall, M H N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: An increasing number and proportion of cancer patients with apparently localised disease are treated with chemotherapy and radiation therapy in contemporary oncology practice. In a pilot study of radiation-induced sarcoma (RIS) patients, we demonstrated that chemotherapy was associated with a reduced time to development of RIS. We now present a multi-centre collaborative study to validate this association. Methods: This was a retrospective cohort study of RIS cases across five large international sarcoma centres between 1 January 2000 to 31 December 2014. The primary endpoint was time to development of RIS. Results: We identified 419 patients with RIS. Chemotherapy for the first malignancy was associated with a shorter time to RIS development (HR 1.37; 95% CI: 1.08–1.72; P =0.009). In the multi-variable model, older age (HR 2.11; 95% CI 1.83–2.43; P
ISSN:0007-0920
1532-1827
DOI:10.1038/bjc.2017.198